Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,418.80
(
0.71%
)
Dow Jones
50,461.68
(
0.00%
)
Brent Oil
94.10
(
-2.97%
)
Bitcoin
75,674.48
(
-0.23%
)
News Focus
News Focus
Post# of 518832
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Talon38

Send PM Follow Ignore
Followers 29
Posts 2263
Boards Moderated 0
Alias Born 12/13/2016

Talon38

Re: mike_dotcom post# 344450

Thursday, 01/13/2022 3:38:38 PM

Thursday, January 13, 2022 3:38:38 PM

Post# of 518832
The dementia/Alzhemer's world is in turmoil and much to the credit of the FDA and Biogen. AVXL will have keep its clinical lead although Wall Street is not much help. The Rett data....when it is released....will give us impetus until P2/3 Alzheimer's dada arrives later this year. This an endurance run!!!
----

https://www.investors.com/news/technology/dnli-stock-biogen-is-not-the-only-alzheimers-company-facing-bad-news/?src=A00220

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News